Decreasing colectomy rates for ulcerative colitis: A population-based time trend study
Kaplan GG, Seow CH, Ghosh S et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study . Am J Gastroenterol 2012; 107: 1879-87.
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): A study of changes in medical treatment and surgical resection rates
Ramadas AV, Gunesh S, Thomas GA et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates . Gut 2010; 59: 1200-6.
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: Results from the CHARM study
Feagan BG, Panaccione R, Sandborn WJ et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study . Gastroenterology 2008; 135: 1493-9.
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
Peyrin-Biroulet L, Oussalah A, Williet N et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease . Gut 2011; 60: 930-6.
Infl iximab and methotrexate in the treatment of rheumatoid arthritis. Antitumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group
Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group
Lipsky PE, van der Heijde DM, St Clair EW et al. Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group. Infl iximab and methotrexate in the treatment of rheumatoid arthritis. Antitumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group . N Engl J Med 2000; 343: 1594-602.